Your browser doesn't support javascript.
Adaptations to the first wave of the COVID-19 pandemic by private sector tuberculosis care providers in India.
Mannan, Shamim; Oga-Omenka, Charity; Soman ThekkePurakkal, Akhil; Huria, Lavanya; Kalra, Aakshi; Gandhi, Ravdeep; Kapoor, Tunisha; Gunawardena, Nathali; Raj, Shekhar; Kaur, Manjot; Sassi, Angelina; Pande, Tripti; Shibu, Vijayan; Sarin, Sanjay; Singh Chadha, Sarabjit; Heitkamp, Petra; Das, Jishnu; Rao, Raghuram; Pai, Madhukar.
  • Mannan S; Clinton Health Access Initiative (CHAI), India.
  • Oga-Omenka C; McGill International TB Centre, Montreal, Canada.
  • Soman ThekkePurakkal A; School of Public Health Sciences, University of Waterloo, Canada.
  • Huria L; Foundation for Innovative New Diagnostics (FIND), India.
  • Kalra A; McGill International TB Centre, Montreal, Canada.
  • Gandhi R; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Canada.
  • Kapoor T; Foundation for Innovative New Diagnostics (FIND), India.
  • Gunawardena N; PATH, India.
  • Raj S; Clinton Health Access Initiative (CHAI), India.
  • Kaur M; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Canada.
  • Sassi A; Centre for Health Research and Innovation (CHRI), India.
  • Pande T; TB PPM Learning Network, Research Institute of the McGill University Health Centre, Canada.
  • Shibu V; McGill International TB Centre, Montreal, Canada.
  • Sarin S; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Canada.
  • Singh Chadha S; McGill International TB Centre, Montreal, Canada.
  • Heitkamp P; PATH, India.
  • Das J; Foundation for Innovative New Diagnostics (FIND), India.
  • Rao R; Foundation for Innovative New Diagnostics (FIND), India.
  • Pai M; McGill International TB Centre, Montreal, Canada.
J Clin Tuberc Other Mycobact Dis ; 28: 100327, 2022 Aug.
Article in English | MEDLINE | ID: covidwho-1936753
ABSTRACT

Background:

India's dominant private healthcare sector is the destination for 60-85% of initial tuberculosis care-seeking. The COVID-19 pandemic in India drastically affected TB case notifications in the first half of 2020. In this survey, we assessed the impact of the first wave of COVID-19 in India on private providers, and changes they adopted in their practice due to the pandemic.

Methods:

The Joint Effort for Elimination of TB (JEET) is a nationwide Global Fund project implemented across 406 districts in 23 states to extend quality TB services to patients seeking care in private sector. We conducted a rapid survey of 11% (2,750) of active providers engaged under JEET's intense Patient Provider Support Agency (PPSA) model across 15 Indian states in Q1 (February-March) of 2021. Providers were contacted in person or telephonically, and consenting participants were interviewed using a web-based survey tool. Responses from participants were elicited on their practice before COVID-19, during the 2020 lockdowns (March-April 2020) and currently (Q1 2021). Data were adjusted for survey design and non-response, and results were summarised using descriptive statistics and logistic regression.

Results:

Of the 2,750 providers sampled, 2,011 consented and were surveyed (73 % response). Nearly 50 % were between 30 and 45 years of age, and 51 % were from Uttar Pradesh, Maharashtra and Gujarat. Seventy percent of providers reported reduced daily out-patient numbers in Q1 2021 compared to pre-COVID times. During the lockdown, 898 (40 %) of providers said their facilities were closed, while 323 (11 %) offered limited services including teleconsultation. In Q1 2021, 88 % of provider facilities were fully open, with 10 % providing adjusted services, and 4 % using teleconsultation. Only 2 % remained completely closed. Majority of the providers (92 %) reported not experiencing any delays in TB testing in Q1 2021 compared to pre-COVID times. Only 6 % reported raising costs at their clinic, mostly to cover personal protective equipment (PPE) and other infection control measures, although 60-90 % implemented various infection control measures. Thirty-three percent of TB providers were ordering COVID-19 testing, in addition to TB testing.To adapt, 82% of survey providers implemented social distancing and increased timing between appointments and 83% started conducting temperature checks, with variation by state and provider type, while 89% adopted additional sanitation measures in their facilities. Furthermore, 62% of providers started using PPE, and 13% made physical changes (air filters, isolation of patient areas) to their clinic to prevent infection. Seventy percent of providers stated that infection control measures could decrease TB transmission.

Conclusion:

Although COVID-19 restrictions resulted in significant declines in patient turn-out at private facilities, our analysis showed that most providers were open and costs for TB care remained mostly the same in Q1 2021. As result of the COVID-19 pandemic, several positive strategies have been adapted by the private sector TB care providers. Since the subsequent COVID-19 waves were more severe or widespread, additional work is needed to assess the impact of the pandemic on the private health sector.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study Language: English Journal: J Clin Tuberc Other Mycobact Dis Year: 2022 Document Type: Article Affiliation country: J.jctube.2022.100327

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study Language: English Journal: J Clin Tuberc Other Mycobact Dis Year: 2022 Document Type: Article Affiliation country: J.jctube.2022.100327